Hemp Health Spolka Akcyjna Logo

Hemp Health Spolka Akcyjna

A vertically integrated supplier of medical cannabis raw material for the Polish market.

HMP | WAR

Overview

Corporate Details

ISIN(s):
PLEBCSL00011 (+4 more)
LEI:
259400HT196UIMTSG008
Country:
Poland
Address:
WARSZAWA JANA STYKI 23, 03-928 WARSZAWA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Hemp & Health S.A. is a company operating at the intersection of the hemp and health sectors. The company's 2024-2025 strategy is centered on creating and managing a vertically integrated supply chain for medical marijuana. Its planned operations span from proprietary cultivation, importation, and processing to the final distribution of medical cannabis as a pharmaceutical raw material. The company's primary strategic objective is to establish itself as a leading Polish entity in the medical cannabis market, controlling the entire value chain to ensure quality and supply.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-05-10 10:55
M&A Activity
Rozpoczęcie negocjacji dotyczących nabycia przez Hemp_Health spółki z branży ma…
Polish 1.2 KB
2024-04-30 13:22
Share Issue/Capital Change
Przydział warrantów subskrypcyjnych serii B - Content (PL)
Polish 831 bytes
2024-04-23 20:47
M&A Activity
Zakończenie negocjacji opisanych w raporcie ESPI nr 5/2024 bez uzyskania porozu…
Polish 845 bytes
2024-04-22 12:22
Major Shareholding Notification
zal01_DC.22.04.2024.FormularzA.pdf
Polish 49.4 KB
2024-04-22 12:22
Major Shareholding Notification
Zmiana stanu posiadania - Content (PL)
Polish 562 bytes
2024-04-15 09:35
Legal Proceedings Report
Złożenie wniosku na import surowca farmaceutycznego przez spółkę stowarzyszoną …
Polish 1.4 KB
2024-03-28 08:33
M&A Activity
Zwrot pożyczonych akcji Cannabis Poland S.A. - Content (PL)
Polish 761 bytes
2024-03-20 21:48
Share Issue/Capital Change
Podwyższenie kapitału zakładowego spółki zależnej w wyniku nowej emisji akcji -…
Polish 707 bytes
2024-02-22 11:36
Share Issue/Capital Change
Zawarcie umowy inwestycyjnej w związku z istotnym dokapitalizowaniem spółki Hem…
Polish 2.4 KB
2024-02-21 12:29
M&A Activity
Podpisanie Term Sheet dotyczącego nabycia plantacji marihuany medycznej przez H…
Polish 1.9 KB
2024-02-12 13:16
Regulatory News Service
Podpisanie Term Sheet z portugalskim zakładem farmaceutycznym przez spółkę stow…
Polish 2.3 KB
2024-02-09 11:35
Regulatory News Service
Otrzymanie zezwolenia na prowadzenie obrotu hurtowego środkami odurzającymi ora…
Polish 1.4 KB
2024-01-22 08:42
M&A Activity
Zawarcie listu intencyjnego dotyczącego przeprowadzenia negocjacji dotyczących …
Polish 1.3 KB
2024-01-15 16:20
Declaration of Voting Results & Voting Rights Announcements
Wykaz akcjonariuszy posiadających co najmniej 5% liczby głosów na Walnym Zgroma…
Polish 934 bytes
2023-12-19 16:35
Proxy Solicitation & Information Statement
zal03_H_H-NWZ-15.01.24-formularz_pelnomocnictwa.pdf
Polish 164.4 KB

Automate Your Workflow. Get a real-time feed of all Hemp Health Spolka Akcyjna filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Hemp Health Spolka Akcyjna via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
AnGes, Inc. Logo
Develops gene-based medicines like HGF gene therapy, DNA vaccines, and NF-kB decoys.
Japan 4563
ANIMALCARE GROUP PLC Logo
Develops & sells veterinary prescription & OTC medicines for professionals worldwide.
United Kingdom ANCR
Annexin Pharmaceuticals AB Logo
Developing Annexin A5 protein to treat vascular, inflammatory, and cancerous diseases.
Sweden ANNX
ANTEROGEN CO., LTD. Logo
Develops and commercializes adult stem cell therapies and orphan drugs for medical conditions.
South Korea 065660
Antibiotice S.A. Logo
Develops and manufactures generic medicines and APIs, specializing in anti-infectives.
Romania ATB
Apontis Pharma AG Logo
German pharma firm specializing in Single Pills for cardiovascular and chronic diseases.
Germany APPH
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases and oncology using its SAFA™ platform.
South Korea 397030
Aprogen Biologics Inc. Logo
Develops and manufactures novel biologic drugs and biosimilars for the professional market.
South Korea 003060
Aprogen, Inc Logo
Develops and manufactures novel biologics and biosimilars for cancer and arthritis treatments.
South Korea 007460
Develops drugs for fibrosis, inflammation, and cancer using NOX inhibitor & CAF modulation tech.
South Korea 293780

Talk to a Data Expert

Have a question? We'll get back to you promptly.